Sean Kim
Stock Analyst at JonesTrading
(0.45)
# 4,051
Out of 4,944 analysts
8
Total ratings
33.33%
Success rate
-14.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRRX DURECT | Downgrades: Hold | n/a | $1.90 | - | 2 | Nov 9, 2023 | |
| ARQT Arcutis Biotherapeutics | Downgrades: Hold | n/a | $15.63 | - | 2 | Nov 8, 2023 | |
| CLSD Clearside Biomedical | Initiates: Buy | $6 | $0.45 | +1,248.31% | 1 | Jun 14, 2023 | |
| OVID Ovid Therapeutics | Initiates: Buy | $6 | $0.86 | +599.30% | 1 | Jun 14, 2023 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $26 | $11.01 | +136.15% | 1 | Jun 14, 2023 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $7 | $7.60 | -7.89% | 1 | Mar 14, 2023 |
DURECT
Nov 9, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.90
Upside: -
Arcutis Biotherapeutics
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $15.63
Upside: -
Clearside Biomedical
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $0.45
Upside: +1,248.31%
Ovid Therapeutics
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $0.86
Upside: +599.30%
EyePoint Pharmaceuticals
Jun 14, 2023
Initiates: Buy
Price Target: $26
Current: $11.01
Upside: +136.15%
Trevi Therapeutics
Mar 14, 2023
Initiates: Buy
Price Target: $7
Current: $7.60
Upside: -7.89%